Recent developments of agents targeting Vibrio cholerae : patents and literature data

JOURNAL ARTICLE published 11 March 2024 in Expert Opinion on Therapeutic Patents

Research funded by EU funding within the NextGenerationEU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases (Project no. PE00000007)

Authors: Francesco Melfi | Simone Carradori | Noemi Mencarelli | Cristina Campestre | Arianna Granese | Mattia Mori

Update on patented cholesterol absorption inhibitors

JOURNAL ARTICLE published August 2009 in Expert Opinion on Therapeutic Patents

Authors: M T Chhabria | B M Mahajan

Leads for the treatment of pulmonary hypertension

JOURNAL ARTICLE published May 2009 in Expert Opinion on Therapeutic Patents

Authors: Michael J Palmer

Preclinical compounds for the treatment of overactive bladder

JOURNAL ARTICLE published February 2009 in Expert Opinion on Therapeutic Patents

Authors: Konstantinos Giannitsas | Angelis Konstantinopoulos | Christos Patsialas | Anastasios Athanasopoulos | Petros Perimenis

Skin antioxidants: assessment of therapeutic value

JOURNAL ARTICLE published July 2003 in Expert Opinion on Therapeutic Patents

Authors: Hans-Peter Podhaisky

Corrigendum

JOURNAL ARTICLE published 3 June 2018 in Expert Opinion on Therapeutic Patents

Possible future therapeutics for Behçet’s syndrome

JOURNAL ARTICLE published January 2007 in Expert Opinion on Therapeutic Patents

Authors: Dr Abdullah Özkiris

Teva Pharmaceuticals v. Sandoz: availability of generic glatiramer acetate and the impact to patent litigation claim construction

JOURNAL ARTICLE published 2 January 2015 in Expert Opinion on Therapeutic Patents

Authors: Louis E Fogel | Chad J Ray

Gene therapy for arthritis 1996 - 1999

JOURNAL ARTICLE published November 1999 in Expert Opinion on Therapeutic Patents

Authors: Uwe Junker | Ernst Böhnlein

JOURNAL ISSUE published May 2000 in Expert Opinion on Therapeutic Patents

Compounds for use in the treatment of mycobacterial infections: a patent evaluation (WO2014049107A1)

JOURNAL ARTICLE published 3 June 2015 in Expert Opinion on Therapeutic Patents

Authors: Dany Pechalrieu | Marie Lopez

Iron chelators as therapeutic iron depletion agents

JOURNAL ARTICLE published November 2006 in Expert Opinion on Therapeutic Patents

Authors: Noah Birch | Xiang Wang | Hyun-Soon Chong

Protein tyrosine phosphatase inhibitors: a patent review (2002 – 2011)

JOURNAL ARTICLE published February 2012 in Expert Opinion on Therapeutic Patents

Authors: Masilamani Elizabeth Sobhia | Stanly Paul | Ranajit Shinde | Mrudula Potluri | Venkatesh Gundam | Amandeep Kaur | Thongtinlal Haokip

Combretastatin-based compounds with therapeutic characteristics: a patent review

JOURNAL ARTICLE published 2 September 2019 in Expert Opinion on Therapeutic Patents

Authors: Lalit Mohan Nainwal | Mohammad Mumtaz Alam | Mohammad Shaquiquzzaman | Akranth Marella | Ahmed Kamal

Pyrazine derivatives: a patent review (June 2012 – present)

JOURNAL ARTICLE published 2 January 2015 in Expert Opinion on Therapeutic Patents

Authors: Martin Dolezal | Jan Zitko

Antifungal azoles for skin disorders

JOURNAL ARTICLE published September 2006 in Expert Opinion on Therapeutic Patents

Authors: H Degreef | J Heeres | M Borgers PhD

Developing trends in pharmaceutical patent claims

JOURNAL ARTICLE published May 1999 in Expert Opinion on Therapeutic Patents

Authors: Trevor Cook

Annotated Patent Selections

JOURNAL ARTICLE published March 2005 in Expert Opinion on Therapeutic Patents

Antisense modulation of Toll-like receptor 4 expression

JOURNAL ARTICLE published December 2003 in Expert Opinion on Therapeutic Patents

Annotated Patent Selections

JOURNAL ARTICLE published July 2004 in Expert Opinion on Therapeutic Patents